Master centre for France

Paris La Défense 92936

0 studies enrolling now · 3 studies all time

What they study most

Congenital Bleeding Disorder, Diabetes Mellitus, Type 2, Haemophilia A, Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R

Studies at this site

• A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3) — Completed
• Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A — Completed
• A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS) — Stopped early